Following this, the company says it will be unable to assess the impact of the ongoing investigations on its financial performance for the FY2023 ending Dec 31.
Cordlife says it will accept the Ministry of Health’s (MOH) decision to suspend the company from collecting new cord blood and human tissues for up to six months. It will also not be submitting written representations to the ministry, which had issued the notice on Nov 30.
The company will also be unable to test, process, store, and provide any new types of tests to its patients during the same period.
